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Summary
Objective: We have examined the occurrence of the inﬂammation-associated inter-alpha-trypsin inhibitor (IaI) components, bikunin, heavy
chain (HC)1 and HC2 in normal cartilage and osteoarthritis (OA) cartilage and synovial ﬂuids.
Design/methods: Cartilage extracts from normal donors and late-stage OA patients, and synovial ﬂuids from OA patients were studied by
Western blot with multiple antibodies to bikunin, HC1 and HC2. Cell and matrix localization was determined by immunohistochemistry and
mRNA by RT-PCR.
Results: Bikuninchondroitin sulfate (CS) and IaI were abundant in OA cartilages, but virtually undetectable in normal. In both OA and normal
cartilages, HCs were largely present in a novel C-terminally truncated 50-kDa form, with most, if not all of these being attached to CS on
a proteoglycan other than bikunin. Synovial ﬂuids from OA patients contained bikuninCS and full-length (w90 kDa) HCs linked to hyaluronan
(HA) as HCHA (SHAPHA). Immunohistochemistry showed intracellular and cell-associated staining for bikunin and HCs, consistent with their
synthesis by superﬁcial zone chondrocytes. PCR on multiple human normal and OA cartilage samples detected transcripts for HC1 and HC2
but not for bikunin. In OA cartilages, immunostaining was predominantly matrix-associated, being most intense in regions with a pannus-like
ﬁbrotic overgrowth.
Conclusion: The truncated structure of HCs, their attachment to a proteoglycan other than bikunin, PCR data and intracellular staining are all
consistent with synthesis of HC1 and HC2 by human articular chondrocytes. The presence of bikuninCS and IaI in OA cartilage, but not in
normal, appears to be due to diffusional uptake and retention through ﬁbrillated (but not deeply ﬁssured) cartilage surfaces.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Inter-alpha-trypsin inhibitor (IaI) is composed of two heavy
chains (HCs), HC1 and HC2 attached by ester linkages to
the single chondroitin sulfate (CS) chain on the proteogly-
can form of bikunin (otherwise known as bikuninCS)1,2.
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1343to inhibition of serine proteinases (e.g., plasmin) by
bikunin3. However, the occurrence of IaI components in
many human tissues4e7 suggested a wider physiological
importance8. In this regard, the role of IaI in delivering
HCs for the covalent modiﬁcation of hyaluronan (HA) to
form HAHC (or SHAPHA) complexes at sites of inﬂamma-
tion9,10, has received much attention (reviewed in Ref. 11).
It is understood that HCHA complexes are generated via
two sequential transesteriﬁcation reactions, where the
C-terminal aspartates of HC1 and HC2 are initially attached,
via ester bonds, to the C-6 hydroxyl groups of N-acetylga-
lactosamine (GalNAc) in the CS chain of bikuninCS during
IaI biosynthesis. Extracellularly, the HCs are transferred
from IaI to TSG-6 (to give TSG-6HC intermediates) and
1344 Y. Yoshihara et al.: Inter-alpha-trypsin inhibitor heavy chains in human cartilagesﬁnally from TSG-6 onto N-acetylglucosamine (GlcNAc) res-
idues of HA12,13.
HCHA has different properties than free HA, which has
been attributed to cross-linking via non-covalent HCeHC
interactions14. HCHA has been implicated in pathological in-
ﬂammation with large amounts present in the synovial ﬂuid of
rheumatoid arthritis patients14,15. In this regard, HCs have
been shown to enhance the binding of HA to CD44, thereby
promoting leukocyte adhesion16. Thus HCHA formation is
a key component of matrix remodeling both in pathological
contexts, where it has been associated with both pro- and
anti-inﬂammatory effects, and in normal physiology. Further-
more, there is evidence that HCsmight form ester linkages to
CS on PGs (proteoglycans) in addition to bikuninCS17,18,
suggesting thatHCsplay adiverse role inmatrix organization.
A role for IaI components in modifying joint disease is sug-
gested by reports on increased concentrations of bikunin,
HCs and/or TSG-6eIaI complexes in the serum or synovial
ﬂuid of RA (rheumatoid arthritis) and osteoarthritis (OA)
patients14,15,19e21. IaI is known to be abundant in serum
and to be synthesized in the liver, but it has also been de-
tected in a variety of other tissues. Here we set out to an-
swer the following questions: (1) Do chondrocytes of
normal human cartilage produce bikunin, HC1 and HC2,
and what complexes do these form in cartilage? (2) Are
there HCHA complexes in human cartilage? (3) Is the abun-
dance or structure of IaI components altered in OA? And (4)
are the IaI components in OA synovial ﬂuid the same as
those found in cartilage? Our novel ﬁndings may provide
new tools for the evaluation of inﬂammatory processes
and turnover of the HA-associated matrix in human OA.
Methods
Many of the materials and methods used here have been described in de-
tail previously22.ANTIBODIESAnti-peptide antibodies to HC1 (JSCQVQ (also called QVQ), against the
sequence 383-QVQESLPELSN-393) and HC2 (JSCEAN (also called EAN)
against the sequence 401-EANNLGLLDPN-411) were prepared by Afﬁnity
Bioreagents, Golden, CO. These were used at 10 mg/ml for immunohisto-
chemistry and 1 mg/ml for Western blot. The anti-bikunin antiserum
(ab43073 (also called 073), from Abcam Inc., Cambridge, MA) was raised
against full-length recombinant human protein and was diluted 1:400 for im-
munohistochemistry and 1:2000 for Western analysis. Anti-peptide antisera
were raised in rabbits by Mimotopes Pty Ltd. (Clayton, Australia) against
the N-terminal peptides of human HC1 (CP7; SATGRSKSSEC), HC2
(CP10; SLPGESEEMMC) and bikunin (CP6; AVLPQEEEGSC) and the C-
terminal peptide of human HC2 (MIM-7; CESTPPPHVMRVE), where the
peptides were coupled to a diphtheria toxoid carrier protein via non-authentic
cysteine residues at their C- or N-termini (see Ref. 23 and Supplementary
Fig. 1 for veriﬁcation of antisera speciﬁcity). The antisera were used at
1:5000 for Western blotting and 1:500 for immunohistochemistry.EXTRACTION OF HUMAN CARTILAGES AND CsCL GRADIENT
CENTRIFUGATIONFemoral condylar cartilage was from ﬁve individuals with no history of joint
disease (age range 28e64 y). The 28 y sample also included tibial plateau car-
tilage and all were usedwithin 24 h of death. The cartilage surfaceswere either
grade 0 (28 y, 29 y, 47 y, and 64 y) or grade 1 (63 y), using the grading system
described previously24. For the grade 1 patient, cartilage was removed only
from the non-ﬁbrillated areas. Osteoarthritic cartilage samples were pooled
from grades 3 and 4 tibial plateaus from seven patients (age range 50e75 y)
undergoing total knee arthroplasty at Henry Ford Hospital under an IRB-
approved protocol. Finely sliced tissue was extracted in 4 M guanidineHCl/
0.05 M sodium acetate/0.1 mM AEBSF (2-aminoethyl)-benzenesulfonyl ﬂuo-
ride)/5 mM EDTA/5 mM iodoacetamide/0.5mg/ml pepstatin (pH 6.8) at 4C for
48 h and, after ﬁltration through glass wool it was run in a dissociative CsCl
gradient (starting density 1.5 g/ml) and fractions D1 (about 1.65 g/ml) through
D6 (about 1.40 g/ml) were dialyzed against water and dried under vacuum.SEQUENTIAL EXTRACTION OF HUMAN CARTILAGESA sequential associative/dissociative extraction protocol was also devel-
oped to examine tissue associations for the different species. This involved
freeze-milling of the cartilage and extraction (3 ml/g wet wt.) with 50 mM
TriseHCl/100 mM NaCl (pH 7.0) for 2 h at 4C (Extract 1) followed by
50 mM TriseHCl/150 mM NaCl/0.5% (w/v) NP-40/0.5% (w/v) deoxycholate
(pH 7.0) for 24 h at 4C (Extract 2) and ﬁnally with 4 M guanidineHCl/
0.01% (w/v) CHAPS/Tris (pH 8.0) for 24 h at 4C (Extract 3). All extractants
contained proteinase inhibitors (one tablet of Complete Miniª, Roche Palo
Alto, CA per 50 ml). Each extract was mixed with three volumes of ice-
cold absolute ethanol, maintained at 20C for 20 h and precipitated macro-
molecules were collected by centrifugation at 16,000g at 4C for 20 min,
washed with ice-cold absolute ethanol and air-dried prior to storage at
20C until analysis. This protocol was applied to cartilage from three grade
0 patients (28 y, 47 y, and 64 y) and the same grade 3/4 pool used for CsCl
gradient analysis (above).ALKALI TREATMENT OF EXTRACTSPortions of Extract 3 (see above) from the grade 3/4 pool, with or without
prior Chase ABC digestion, were dried, dissolved in 10 ml of 0.2 M NaOH and
maintained at room temperature for 2 h. Samples were neutralized by
addition of 1 ml of 2 M HCl, then mixed with 15 ml of 1.6-fold concentrated
gel-loading buffer22 containing DTT (dithiothreitol) for Western blot analysis.SYNOVIAL FLUID FRACTIONATIONSynovial ﬂuid was obtained from 5 patients (52e75 y who were undergoing
an IRB-approved protocol at Henry Ford Hospital) with knee effusions associ-
ated with degenerative arthritis having clinically required knee aspiration with
or without injection. Patients with evidence of crystal disease or inﬂammatory
arthritis such as gout were eliminated, as were patients who had received any
joint injection within the preceding 3 months. Samples were pooled (w100 ml
total) and adjusted to 4 M guanidineHCl (with two tablets of Complete Miniª,
Roche Palo Alto, CA) and a starting density of 1.5 g/ml with CsCl prior to ultra-
centrifugation. Fractions D1 (about 1.65 g/ml) through D6 (about 1.40 g/ml)
were prepared, exhaustively dialyzed against water and dried under vacuum.WESTERN BLOT ANALYSIS OF CARTILAGE EXTRACTS AND
GRADIENT FRACTIONSPortions of desalted and dried tissue extracts and CsCl gradient fractions
were treated with glycosidases prior to gel electrophoresis as follows. For
Chondroitinase ABC (Chase) digestion, samples were dissolved in 50 mM
Na-acetate/50 mM TriseHCl/5 mM EDTA/0.1 mM AEBSF, pH 7.6, and di-
gested with proteinase-free Chase from Proteus vulgaris (Seikagaku, Inc.)
(25 mU per 100 mg S-GAG (sulfated glycosaminoglycans)) at 37C for 2 h.
For hyaluronidase digestion, samples were resuspended in 100 mM ammo-
nium acetate/5 mM EDTA/0.1 mM AEBS F ((2-aminoethyl)-benzenesulfonyl
ﬂuoride), pH 6.0 and digested at 60C for 3 h with 0.5 TRU (turbidity reducing
units) hyaluronidase (Hyase) from Streptomyces hyalurolyticus (Seikagaku,
Inc.) per 100 mg S-GAG. Untreated samples were dissolved in the same
buffers and incubated at the same temperature without deglycosidases. After
incubation, samples were dried and dissolved in gel-loading buffer containing
DTT before separation on SDS-PAGEs and Western blot analysis as
described22.IMMUNOHISTOCHEMISTRY OF HUMAN CARTILAGESFemoral condyle or tibial plateau cartilages were removed from the bone
with a scalpel and rinsed in ice-cold PBS25. For one donor (45 y male with no
history of joint disease, scored as grade 024) cartilage was taken from one
location (Site 1, medial notch, non-weight-bearing and showing smooth sur-
face). For a second donor (63 y male with no history of joint disease, scored
as grade 1) cartilage was removed from four sites on the femoral surface
(Site 1, medial notch, non-weight-bearing and showing minor surface rough-
ening; Site 2, center of patellar groove, showing advanced surface ﬁbrillation;
Site 3, lateral patellar groove with smooth surface; Site 4, lateral femoral
condyle, weight bearing with smooth surface). For a third donor (72 y male
undergoing total knee arthroplasty and scored as grade 4) tissue was taken
from a central region of severely eroded medial tibial plateau cartilage as
described in Ref. 22. Full depth, 5-mm diameter plugs were prepared, placed
into 10% (v/v) neutral-buffered formalin for 48 h, followed by decalciﬁcation in
5% (w/v) EDTA in PBS for 14 days, before processing, parafﬁn embedding
and sectioning as described. Immunohistochemistry was performed after
deparafﬁnization as described26. Pretreatment of sections with Chase ABC
or Streptomyces Hyase did not alter the intensity or distribution of immuno-
reactivity for any of the antibodies used. On the other hand, mild proteinase
K digestion, commonly used for antigen retrieval26, completely abolished
immunoreactivity for all antibodies used here.
Table I
Primer sequences, annealing temperatures and amplicon sizes of
cDNAs used to assess expression of Coll II, TSG-6, bikunin,
ITIHCs-1, -2, and -3, and EF1a in human articular cartilage
Target Primer sequence Annealing
temperature
((C)
Amplicon
size
Coll II S TGGGGCCTTGTTCACCTTTGA 62 380
A CCGAGGCAACGATGGTCAGC
TSG-6 S ACCACAGAGAAGCACGGTCT 62 164
A CAACTCTGCCCTTAGCCATC
Bikunin S TACATCCATGGCCTGTGAGA 60 395
A TTTATTTGGACCCAGGTTGC
ITIHC-1 S GACCCCAACACAGGCTTCTC 62 304
A TTCCACACTCGGTGCAAAAC
ITIHC-2 S CGGCTCAAGTCACGAATCAG 60 408
A TTGTAATCCCCGTCAATCAA
ITIHC-3 S CAGTGCTGCGCCTTATTCAG 62 485
A ATGTGGCATCTGGCTTTGTG
EF1a S AAAATGACCCACCAATGGAA 62 210
A GCAGCATCACCAGACTTCAA
1345Osteoarthritis and Cartilage Vol. 16, No. 11ARTICULAR CARTILAGE COLLECTION FOR PCR ASSAYSSamples were collected from total knee arthroplasty tissues, in accor-
dance with an IRB approval and categorized as ‘‘intact’’ or ‘‘ﬁbrillated’’, based
on the gross surface appearance. Cartilage was ﬁnely sliced, rinsed with
PBS and pulverized under liquid nitrogen. RNA was extracted usingFig. 1. Western blot analyses of bikunin in CsCl gradient fractions prep
(grades 3e4) human cartilage. Fractions from normal cartilages (left) a
073, without (panels a and c) and with (panels b and d) Chase ABC dig
cartilage for both normala previously described protocol33. Brieﬂy, 1e2 g of pulverized cartilage
was homogenized in guanidinium isothiocyanate buffer, extracted with acidic
phenol:chloroform, and precipitated with sodium acetate and isopropanol.
The precipitate was processed through an ‘‘RNA clean-up’’ protocol (Invitro-
gen) with on-column DNase treatment. RNA was eluted with DEPC (diethyl-
pyrocarbonate) -treated water and 0.5 mg of RNA from each sample was
electrophoresed through formaldehyde agarose gels and stained with ethid-
ium bromide to verify ribosomal RNA integrity. One microgram of RNA was
reverse-transcribed using oligo T primers (Superscript II ﬁrst strand synthesis
kit, Invitrogen) and 1 ml of the product used for PCR. Primers were designed
using Primer3 version 0.4.0 software34. Primer sequences, annealing tem-
peratures and amplicon sizes for each reaction are provided in Table I. All
reactions involved an initial 3-min 95C denaturation step, 15-s annealing
times and 20-s extension times, and were continued for 30e45 cycles.
Collagen type II (Coll II) was assayed as a chondrocyte-speciﬁc marker, while
elongation factor 1 alpha (EF1a) was used to demonstrate approximately
equal mRNA quantities. RNAs from human cell lines were used to optimize
PCR conditions and as positive controls for the reactions (Fig. 12). Reactions
lackingRT templatewere used as negative controls. ThePCRamplicons were
cloned and sequenced to verify cDNA identities. Aliquots (20 ml) of each PCR
reaction were electrophoresed in 2.0% agarose gels, stained with ethidium
bromide and photographed using a Kodak EDAS 290 gel-imaging system.ResultsCHARACTERIZATION OF BIKUNIN, HC1 AND HC2 IN
CARTILAGE EXTRACTSCartilage pools from normal donors (grades 0e1) and OA
patients (grades 3e4) were extracted with 4 M guanidi-
neHCl and fractionated by CsCl gradient centrifugation.
Fractions D1 through D6 from each group were analyzed
by Western blotting with antibodies for bikunin (Fig. 1),
HC1 (Fig. 2), HC2 (Fig. 3); data for untreated samplesared from guanidineHCl extracts of normal (grades 0e1) and OA
nd OA cartilages (right) were analyzed for bikunin with antibody
estion. The portions loaded corresponded to about 2 mg wet wt. of
and OA samples.
Fig. 2. Western blot analyses of HC1 in CsCl gradient fractions prepared from guanidineHCl extracts of normal (grades 0e1) and OA (grades
3e4) human cartilage. Fractions from normal cartilages (left) and OA cartilages (right) were analyzed for HC1 with antibody QVQ, without
(panels a and c) and with (panels b and d) Chase ABC digestion. The portions loaded corresponded to about 2 mg wet wt. of cartilage for
both normal and OA samples.
Fig. 3. Western blot analyses of HC2 in CsCl gradient fractions prepared from guanidineHCl extracts of normal (grades 0e1) and OA (grades
3e4) human cartilage. Fractions from normal cartilages (left) and OA cartilages (right) were analyzed for HC2 with antibody EAN, without
(panels a and c) and with (panels b and d) Chase ABC digestion. The portions loaded corresponded to about 2 mg wet wt. of cartilage for
both normal and OA samples.
Fig. 4. Western blot analyses of HC1 and HC2 with multiple antibodies. Portions of guanidineHCl extracts (sequential Extract 3) of OA car-
tilage were analyzed for HC1 with antibodies QVQ and CP7 (panel a), and for HC2 with antibodies EAN and MIM-7 (panel b), both without ()
and with (þ) Chase ABC digestion. Portions of the CsCl fraction D4 of OA synovial ﬂuids were analyzed with EAN and MIM-7 for HC2 with (þ)
Chase ABC digestion. The portions loaded corresponded to about 2.5 mg wet wt. of cartilage or 8.5 ml synovial ﬂuid.
Fig. 5. Western blot analyses of associative and dissociative extracts from normal and OA cartilages. Portions of sequential Extracts 1e3 (see
Methods for details) from normal (panels aec) and OA (panels def) cartilage were analyzed for bikunin with antibody 073 (panels a and d),
HC1 with antibody QVQ (panels b and e) and HC2 with antibody EAN (panels c and f), without () and with (þ) Chase ABC digestion. The
portions loaded corresponded to about 5 mg wet wt. of cartilage for both normal and OA samples.
Fig. 6. Release of HC1 by treatment of extracts of normal cartilage
with Chase ABC or alkali. Portions of guanidineHCl extracts (se-
quential Extract 3) of normal cartilage were analyzed for HC1
(with antibody QVQ) when untreated (lane 1), digested with Chase
ABC (lane 2), alkali treated (lane 3) or after both Chase ABC and
alkali treatment (lane 4). The portions loaded corresponded to
about 2.5 mg wet wt. of cartilage.
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and d) are shown in each case. The 073 antibody revealed
that extracts of normal cartilage contained trace amounts of
bikuninCS (w45 kDa) in the D5 and D6 fractions [Fig. 1(a)],
and this species was converted to the corresponding
w30-kDa core protein after Chase treatment [Fig. 1(b)]. In
addition, both low buoyant density fractions contained an
immunoreactive species migrating with a molecular weight
of w250 kDa, and its removal after Chase treatment is in
keeping with it representing intact IaI12,27. In extracts from
OA cartilage both the bikuninCS and the IaI were signiﬁ-
cantly more abundant in fractions D5 and D6 compared to
normal cartilage [Fig. 1(c)] with an additional chondroiti-
nase-sensitive species migrating with a molecular weight
of 130 kDa [Fig. 1(c, d)]. The latter has a molecular weight
similar to pre-alpha-inhibitor (PaI: bikuninHC3), however,
Western blot analysis of these samples with HC3-speciﬁc
antibodies from two different sources showed no immunore-
activity (data not shown). The bikunin-positive species
migrating at w60 kDa [Fig. 1(aed), band 1, Chase ABC-
insensitive] and w55 kDa [Fig. 1(b, d); band 2, Chase
ABC-generated], were not characterized but were also
detected using the CP6 antiserum, raised against the N-
terminus of bikunin (data not shown).
With respect to HC1 and HC2, use of antibodies QVQ
and EAN, respectively, showed that both normal and OA
cartilage extracts contained a small amount of unbound,
full-length HCs (w90 kDa)12,13,28, in the D5 and D6 frac-
tions [Figs. 2(a, c) and 3(a, c)]. Digestion of both normal
and OA gradient fractions with Chase ABC-generated
abundant HC1 and HC2 species, which migrated with unex-
pectedly low molecular weights of about 50 kDa [Fig. 2(b,
d), truncated HC1; Fig. 3(b, d), truncated HC2]. Such short
HC2 is also detectable prior to Chase ABC treatment. The
proportions of full-length and truncated forms of HC1 andHC2 appeared to be similar for the two HCs (perhaps
1:20) with little difference in protein levels between normal
and OA samples. However, the short forms of HC1 and
HC2 were the dominant species attached to GAG (glycos-
aminoglycan), and thus released by Chase ABC. The iden-
tities of the minor HC1-positive species at about 55 kDa
[Fig. 2(d)] and the HC2-positive species at about 130 kDa
[Fig. 3(b)], 55 kDa and 75 kDa [Fig. 3(d)] are unknown. No-
tably, both the 55 kDa and 75 kDa HC2-positive species
were also recognized by the MIM-7 antiserum, raised
against the C-terminus of HC2 (data not shown).ANALYSIS OF TRUNCATED FORMS OF HC1 AND HC2
IN CARTILAGE EXTRACTSTo further deﬁne the composition of the truncated HCs in
OA cartilage extracts, samples were analyzed by Western
blotting with two HC1-speciﬁc antibodies (QVQ and CP7)
and three HC2-speciﬁc antibodies (EAN, CP10 and
MIM-7) (see Methods and Supplementary Fig. 1, for de-
tails). We found that truncated HC1 reacted with both
QVQ and the N-terminus-speciﬁc CP7 [Fig. 4(a)]. However,
the truncated HC2 reacted with anti-EAN but not with the
C-terminus-speciﬁc MIM-7 [Fig. 4(b)] or the N-terminus-
speciﬁc CP10 (data not shown). This suggests that trun-
cated HC2 lacks the C-terminal region and the N-terminus,
whereas truncated HC1 lacks only the C-terminal region.
This interpretation for HC2 is supported by the fact that
both EAN and MIM-7 did detect the 90 kDa form of HC2
in Chase ABC-digested portions of CsCl fractionated OA
synovial ﬂuids [Fig. 4(c), arrow]. With respect to the
50 kDa forms, it is signiﬁcant that antisera to the N-terminus
of HC1 (CP7) and HC2 (CP10) also detect 50-kDa species
in preparations of IaI puriﬁed from human serum, whereas
MIM-7 does not (see Supplementary Fig. 1). The 50 kDa
species in serum and cartilage may not be identical, partic-
ularly since only the cartilage species are CS-bound and
the CP10 antibody detects HC2 in serum but not in cartilage
extracts. CP10 did, however, react with a 60 kDa form of
HC2 in CsCl gradient fractions of OA cartilage and synovial
ﬂuids (data not shown) and also cell cluster-associated HC2
on immunohistochemistry (Fig. 10).RECOVERY OF BIKUNIN AND HCs IN EXTRACTS OF NORMAL
AND OA CARTILAGESTo explore the extracellular associations of bikunin, HC1,
HC2 in normal and OA cartilages, we applied a three-step
sequential extraction protocol (see Methods for details)
followed by Western blot analysis without and with Chase
ABC digestion (Fig. 5). The data demonstrated that IaI,
the putative PaI (or bikunin with a single HC) (at 130 kDa),
and the bikuninCS (at 45 kDa) are essentially present
only in OA tissue [Fig. 5(d)]. In addition the analyses
showed that these species are quantitatively extracted by
isotonic salt (Extract 1) or isotonic salt plus detergent (Ex-
tract 2) and did not require 4 M guanidineHCl (Extract 3)
for solubilization. The molecular basis for the doublet of
bikunin-positive material at 120e140 kDa in unfractionated
Extracts 1 and 2 from OA cartilage [Fig. 5(d)] is unknown.
However, on long exposure of the anti-HC1 (QVQ) and
anti-HC2 (EAN) blots of such extracts, it was observed
that the HC antibodies reacted only with the faster migrating
band. Since there was no evidence for unprocessed, full-
length HCs in these samples, this may represent bikuninCS
substituted with truncated HCs. This also suggests that the
more abundant, slower band represents PaI [bikuninHC3,
Fig. 7. Western blot analyses of CsCl gradient fractions generated from osteoarthritic synovial ﬂuid pool. Fractions were analyzed for bikunin
(panel a), HC1 (panel b) and HC2 (panel c) both without () and with (þ) Chase ABC digestion (panel a) or without () and with (þ) Strep-
tomyces Hyase digestion (panels b and c). The portions loaded corresponded to about 2.5 ml of synovial ﬂuid for bikunin and about 8.5 ml of
synovial ﬂuid for HC1 and HC2. The doublet at 64 kDa and 68 kDa (most evident on the HC2 blots) appears to be non-speciﬁc, since we have
detected it on blots with many antibodies unrelated to this study.
1349Osteoarthritis and Cartilage Vol. 16, No. 11see Fig. 1(c) and text]. The ﬁnding that the 250 kDa IaI was
barely detectable in these unfractionated extracts of OA
cartilage (but readily detected in the D6 of CsCl gradient
fractions, [Fig. 1(c)]) may be due to an association of IaI
with other components which may have prevented it from
entering the gel or resulted in low immunoreactivity due to
masking on the membrane.TRUNCATED HCs ARE PRIMARILY LINKED TO A CSPG IN
CARTILAGE EXTRACTSThe covalent linkage of truncated HCs to HA or CS via
ester bonds (Figs. 2e5) in both normal and OA cartilages,
was further supported by the alkali sensitivity of the HC1
complex in Extract 3 material (Fig. 6). The 50 kDa species
was absent from untreated extracts (lane 1), but was gener-
ated by Chase ABC digestion (lane 2), alkali treatment (lane
3) or by a combination of both treatments (lane 4). Digestion
of such complexes from normal and OA samples with
Streptomyces Hyase (under conditions which quantitatively
degraded uncomplexed HA or HA in A1-aggrecan-
aggregates), did not, however, generate detectable ‘‘free’’HCs (data not shown) suggesting that HCHA complexes
are not abundant in cartilage. In addition, when samples
were treated with keratanase II or endo-b-galactosidase
(or both enzymes), there was no marked change in HC2
or bikunin migration properties (data not shown). The data
illustrated in Fig. 6 also indicate that the apparent doublet
corresponding to truncated HCs [see also Fig. 5(e, f)] may
be explained by variable O-linked glycosylation since
Chase ABC digestion alone generated a slower migrating
band than that produced by treatment with alkali.
The HCs on circulating IaI are attached to bikuninCS by
ester linkages11. However, analysis of the distribution of
HCs and bikunin in cartilage extracts suggested that a signif-
icant proportion of HCs, particularly in normal cartilages, is
present on a CSPG other than bikunin. This was readily
seen on analysis of CsCl gradient fractions of normal carti-
lage where fractions containing abundant HC1 and HC2
[Figs. 2(b) and 3(b), fractions D4 and D3] were apparently
devoid of bikunin [see Fig. 1(b)], a conclusion which was
also supported by extended exposure of the Western for
bikunin. Analysis of the D3 fraction from OA cartilage
[Figs. 1(d), 2(d) and 3(d)] was also consistent with this
Fig. 8. Immunohistochemical localization of bikunin in femoral condylar cartilages. Cartilage from the medial notch of a normal 45 y male and
four separate sites on the femoral surface of a 63 y male with no history of joint disease (see Methods for details of sites and gross appearance
of cartilage surfaces) were processed for immunohistochemical staining for bikunin. Images were taken at 4 and 20 magniﬁcation (upper
and lower images in panels aec, respectively) or 40 (panel d). Panel a (left), Site 1 from 45 y male and panel a (right), Site 1 from 63 y male
both stained with 073. Panel b (left), Site 1 from 45 y male and panel b (right), Site 1 from 63 y male stained with CP6. Panel c, Sites 2e4 were
stained with 073. Panel d (left), cell-associated staining in Site 1 from 45 y male. Panel d (middle and right), cell-associated staining in Site 1
from 63 y male. Antibodies were 073 (left and middle) and CP6 (right).
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3 from both normal and OA cartilages (Fig. 5, see white
arrows) contained abundant HC1 and HC2, but essentially
undetectable bikunin, even after extended ﬁlm exposure.ANALYSIS OF OSTEOARTHRITIC SYNOVIAL FLUIDSTo determine whether the bikunin and HC complexes
identiﬁed in OA cartilage were deposited after diffusion
from the synovial ﬂuid, we examined ﬂuid from outpatients
undergoing clinically required joint drainage. Pooled ﬂuids
were subjected to dissociative CsCl gradient centrifugation
(starting density 1.5 g/ml) and fractions D1 through D6 were
digested with either Chase ABC or Streptomyces Hyase,
followed by Western analysis (Fig. 7). The D3 to D6
fractions contained abundant bikuninCS at 45 kDa
[Fig. 7(a), left-hand panel], which was converted to
30 kDa bikunin core protein [Fig. 7(a), right-hand panel] fol-
lowing Chase ABC digestion. There was, however, no evi-
dence for IaI complexes [see Fig. 1(c), for example] in the
OA synovial ﬂuid pool, suggesting that the abundant
bikuninCS [Fig. 7(a)] represents a by-product generatedby TSG-6-mediated transfer of HCs from serum- or joint tis-
sue-derived IaI onto HA in the joint space of these individ-
uals. Consistent with this was the ﬁnding that full-length
HC1 and HC2 [90 kDa, Fig. 7(b, c), right-hand panels]
were released after Streptomyces Hyase digestion of the
D5 and D6 fractions. Interestingly, the truncated HCs
were not detectable in these fractions either before or after
Hyase treatment. In addition, no truncated HCs, and only
trace amounts of the 90 kDa HCs, were generated by
Chase ABC digestion (data not shown). The identity of
the other major species at 25e30 kDa, 55 kDa and
75 kDa detected by the HC1- and HC2-speciﬁc antibodies
[Fig. 7(b, c)] is unknown, however, the 55 kDa and 75 kDa
species also appear to be present in extracts of OA carti-
lages (see Figs. 2 and 3) and they might represent HC deg-
radation products.IMMUNOHISTOCHEMICAL LOCALIZATION OF BIKUNIN, HC1
AND HC2 IN NORMAL AND OA CARTILAGESAs the biochemical data described above were obtained
from cartilage pools (ﬁve normal donors and seven OA
Fig. 9. Immunohistochemical localization of HC1 in femoral condylar cartilages. Cartilage from the medial notch of a normal 45 y male and four
separate sites on the femoral surface of a 63 y male with no history of joint disease (see Methods for details of sites and gross appearance of
cartilage surfaces) were processed for immunohistochemical staining for HC1. Images were taken at 4 and 20 magniﬁcation (upper and
lower images in panels aec, respectively) or 40 (panel d). Panel a (left), Site 1 from 45 y male and panel a (right), Site 1 from 63 y male
stained with QVQ. Panel b (left), Site 1 from 45 y male and panel b (right), Site 1 from 63 y male stained with CP7. Panel c, Sites 2e4 stained
with QVQ. Panel d (left), cell-associated staining in Site 1 from 45 y male. Panel d (middle and right), cell-associated staining in Site 1 from
63 y male. Antibodies were QVQ (left and middle) and CP7 (right).
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kunin and HCs in cartilages of different histopathological
appearance; in addition the extraction data do not indicate
whether the resident chondrocytes might be the biosyn-
thetic source of bikunin and HCs. Therefore, immunohisto-
chemical staining for bikunin (Fig. 8), HC1 (Fig. 9) and
HC2 (Fig. 10) was done on sections of different histopatho-
logical appearance from the normal 45 y male donor (Site
1), the normal 63-y-old male donor (Sites 1e4) and the
72 y male donor undergoing joint replacement for OA
(Fig. 11).
For bikunin, a comparison of the location-matched Site 1
samples [Fig. 8(a)] showed that the sectionwith a smooth sur-
face (left) showed no speciﬁc staining in either cells ormatrix,
whereas the section with a ﬁbrillated surface (right) showed
intense staining of cell groups in the ﬁbrillated regions. Fur-
thermore, speciﬁcity of the immunostaining for bikunin with
073 was veriﬁed by use of a second antibody CP6
[Fig. 8(b)]. The presence of cell-associated bikunin near ﬁbril-
lated surfaces was conﬁrmed with Site 2 sections [Fig. 8(c)].
Tissue from Sites 3 and 4, [Fig. 8(c)] showed that in someregionswith amacroscopically smooth surface, isolated cells
or groups of cells in the superﬁcial regions stained weakly
positive for bikunin. High-magniﬁcation images of staining
in cell groups from the two Site 1 samples showed that for
both antibodies the cell-associated and intracellular staining
[Fig. 8(d), arrows] was most noticeable around cell groups
that also showed intense methyl-green (anionic) staining in
the cell-associated matrix. This suggests that increased la-
beling for bikunin is associated with increased de novo PG/
GAG production in damaged regions of cartilage.
For HC1, individual cells in the superﬁcial region of all
sections with a smooth surface were stained at a low or me-
dium intensity [Fig. 9(a, b), left-hand panels and Fig. 9(c),
right-hand panel] but there was no detectable staining in
the transitional or radial zones of the same tissue section
(see Ref. 29 for deﬁnition of cartilage zones). On the other
hand, there were marked increases in cell-associated
staining in the superﬁcial region of all sites with a ﬁbrillated
surface, whether the ﬁbrillation was slight or deep [Fig. 9(a,
b), right-hand panels and Fig. 9(c), two left-hand panels].
Speciﬁcity of staining for HC1 with QVQ was also conﬁrmed
Fig. 10. Immunohistochemical localization of HC2 in femoral condylar cartilages. Cartilage from the medial notch of a normal 45 y male and
four separate sites on the femoral surface of a 63 y male with no history of joint disease (see Methods for details of sites and gross appearance
of cartilage surfaces) were processed for immunohistochemical staining for HC2. Images were taken at 4 and 20 magniﬁcation (upper and
lower images in panels aec, respectively) or 40 (panel d). Panel a (left), Site 1 from 45 y male and panel a (right), Site 1 from 63 y male
stained with EAN. Panel b (left), Site 1 from 45 y male and panel b (right), Site 1 from 63 y male stained with CP10. Panel c, Sites 2e4 stained
with EAN. Panel d (left), cell-associated staining in Site 1 from 45 y male. Panel d (middle and right), cell-associated staining in Site 1 from 63 y
male. Antibodies were EAN (left and middle) and CP10 (right).
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the cellular staining, some regions of the surface, the under-
lying matrix and the inter-territorial matrix around cell
groups showed a diffuse positive staining pattern with
both antibodies (see black arrows on panels aec). High-
magniﬁcation images [Fig. 9(d)] of staining in cell groups
from the two Site 1 samples conﬁrmed that staining with
both antibodies appeared to be primarily intracellular with
some reactivity at the margins of the cell-associated matrix
(see arrows).
For HC2, individual cells in the superﬁcial region of all
sections with a smooth surface stained at low intensity
[Fig. 10(a, b), left-hand panels and Fig. 10(c), right panels].
As for HC1, there was a marked increase in cell-associated
staining in the superﬁcial region of all sites with a ﬁbrillated
surface [Fig. 10(aec)]. Also similar to HC1, there was no
staining in the transitional or radial zones, but some matrix
staining at the surface and around cell groups with both
HC2 antibodies (see black arrows). Speciﬁcity of staining
for HC2 with EAN was conﬁrmed with a second antibody,
CP10 [Fig. 9(b)]. High-magniﬁcation images of cells fromthe two Site 1 samples showed that HC2 staining with
both antibodies appeared to be predominantly intracellular,
even in cells that were undergoing mitosis [Fig. 10(d), right-
hand panel]. In addition, the ﬁnding that the staining pattern
for HC1 and HC2 was conﬁned to the superﬁcial zone of
Site 3 (63 y male) was supported by Western analysis of
extracts of the individual zones (data not shown).
For cartilages taken from the late-stage OA joints, two
distinct staining patterns were observed (Fig. 11). Firstly,
in regions with a deeply ﬁssured cartilage surface, cell
groups in the superﬁcial zone, and adjacent to ﬁssures,
stained positive for HC1 and HC2, [Fig. 11(b, c), left-hand
panels], but bikunin staining was virtually absent
[Fig. 11(a), left-hand panel]. Secondly, other areas of carti-
laginous tissues taken from the same tibial plateau, showed
less apparent surface damage [Fig. 11(aec), right-hand
panels] and these had a thick superﬁcial layer of cartilagi-
nous matrix, in which all three components (bikunin, HC1
and HC2) were markedly stained, both throughout the
matrix and associated with the cells (high-magniﬁcation im-
ages, panels aec). It is possible that this intensely-stained
Fig. 11. Immunohistochemical localization of bikunin, HC1 and HC2 in late-stage osteoarthritic human tibial plateau cartilage. Full depth car-
tilage from the tibial plateau of a 72 y male undergoing joint replacement (see Methods for details) was processed for immunohistochemical
staining for bikunin (antibody 073, panel a), HC1 (antibody QVQ, panel b) and HC2 (antibody EAN, panel c). Images were taken at 4 and
20 magniﬁcation (upper and lower images in panels aec, respectively). Two markedly different tissue morphologies and staining patterns
were observed. The left-hand panels of aec show the appearance in areas with gross surface ﬁbrillation. The right-hand panels of aec and the
high-magniﬁcation images below show the appearance in areas with an intact and apparently overgrown surface.
1353Osteoarthritis and Cartilage Vol. 16, No. 11tissue represents a de novo cartilaginous overgrowth from
a reparative attempt, and that it contains proteins originating
from the resident tissue cells as well as some derived by dif-
fusion from the synovial ﬂuid. This form of intensely-stained
matrix may explain our observations (Fig. 5), that a pool of
associatively extractable bikunineHC complexes are much
more abundant in OA cartilage than normal cartilages.ANALYSIS OF HUMAN CARTILAGES FOR mRNAs FOR BIKUNIN,
HCs AND TSG-6To determine whether human cartilages have the capac-
ity to synthesize bikunin, HC1, HC2, HC3 and TSG-6 (the
mediator for HC transfer to HA from CS), we did RT-PCR
analysis for these transcripts in cartilage samples (from
six separate patients) which on gross examination had an
intact glossy surface or a ﬁbrillated surface (Fig. 12). Colla-
gen II transcripts were analyzed as a positive cartilage
control and EF1a as an internal loading control. We found
clear evidence for the presence of HC1, HC2, HC3 and
TSG-6 transcripts with no consistent differences between
the cartilage types. On the other hand we were unable to
detect transcripts for bikunin.Discussion
Our data suggest strongly that HC1 and HC2 are synthe-
sized by human articular chondrocytes in a novel truncated
form attached to a CSPG other than bikunin. On the other
hand, the bikunin present in cartilage extracts (much more
abundant in OA tissue and associated with cells near ﬁbril-
lated surfaces) appears to be derived from the circulation by
diffusion from the synovial ﬂuid into the cartilage. Our West-
ern analysis of HC1 and HC2 suggests that the truncated
forms are present in similar abundance in normal and
advanced OA tissues which appears to conﬂict with a recent
proteomic analysis30 reporting a massive increase in HC2
in OA tissues; this difference might, however, be explained
by patient and donor tissue selection.
The presence of truncated HCs in human cartilage may
be due to alternate mRNA splicing or a novel upstream
truncation of the proteins during Golgi processing18. If, as
seems likely, the addition of these 50 kDa HCs to CS
occurs by addition to a C-terminal aspartic acid (as occurs
with extended HCs18), then this would require that chondro-
cyte HCs be cleaved (by what is thought to be an autocat-
alytic event) at a consensus Asp-X-Asp-Pro site(s)18 during
Fig. 12. RT-PCR ampliﬁcation of Coll II, bikunin (BIK), TSG-6,
ITIHCs-1 (HC1), -2 (HC2) and -3 (HC3), and EF1a mRNAs in
human articular cartilage samples. Details of the PCR primers
and reaction conditions are provided in Table I and Methods. Six
separate patients were analyzed and results are shown for
mRNA isolated from cartilages with a ﬁbrillated surface (lanes
1e3) or an intact surface (lanes 4e6).
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(the full-length product is cleaved at DTD672P673) and at
DGD423P424 in HC2 (the full-length product is cleaved at
END702P703). In this regard, structural studies of IaI puriﬁed
from human serum31 have shown that they contain quite
large amounts of 50 kDa HC1 and HC2, with similar
immunoreactivity proﬁles to those in cartilage extracts
(Supplementary Fig. 1; C. M. Milner and A. J. Day, unpub-
lished observation).
Analysis of the relative abundance of bikunin and HCs in
CsCl gradient fractions of normal cartilage extracts [Figs.
1(b), 2(b) and 3(b)] and in the ﬁnal guanidineHCl extract
of the sequential protocol (Fig. 5) revealed the presence
of a pool of CS-bound HCs in cartilage which was appar-
ently not associated with bikunin. While the nature of this
CSPG is unknown, it is relevant that co-expression of
decorin, a major chondrocyte product, with HC3 in COS-1
cells has been shown to generate complexes with HC3
covalently attached to the CS of decorin18. Further, charac-
terization of the HCs in human follicular ﬂuid has shown
a proportion to be covalently attached to the CS chains of
versican17, which is also synthesized by chondrocytes.
Immunohistochemical analysis for bikunin, HC1 and HC2
of tissue from an individual with entirely normal femoral
cartilage (45 y, grade 0) and multiple sites from another
with early degenerative cartilage changes (63 y, grade 1)
revealed an interesting difference in their distribution. Biku-
nin-positive cells were only present in cell groups present
under ﬁbrillated surfaces in low-grade cartilage, whereas
HC-positive cells were found in cell groups under ﬁbrillated
surfaces and also under smooth surfaces where there was
ﬁbrillation elsewhere in the joint; also a diffuse matrix stain-
ing was often seen for HCs but never for bikunin. This is
consistent with the idea that the HCs are primarily synthes-
ised by the chondrocytes whereas the bikunin is derived
from the synovial ﬂuid. In this regard, synovial ﬂuids from
RA14 and OA32 patients have been shown to contain HCslinked to HA. Our analysis of CsCl gradient fractions from
a pool of synovial ﬂuids derived from OA patients under-
going joint drainage showed the presence of abundant
bikuninCS and also some 90 kDa HCs (but not 50 kDa
HCs) linked to HA but not CS. These analyses are consis-
tent with the synovial ﬂuid products being derived from
non-cartilage sources and further indicate that the cartilage
species are derived primarily from the resident chondro-
cytes. Further work is needed to describe the details of
chondrocyte-mediated biosynthesis of the truncated HCs
and the CSPG to which they are complexed. Unravelling
these details may provide a means to use speciﬁc IaI
structures to monitor chondrocyte-speciﬁc responses to
progressive joint disease.Conﬂict of interest
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